Fredun Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE194R01017
NSEID:
BSEID: 539730

INR

654.95

9.85 (1.53%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.59 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2024 is 17.53% vs 11.59% in Dec 2023

Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 26.30% vs 21.97% in Dec 2023

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is 25.88% vs 43.58% in Dec 2023

Interest

YoY Growth in quarter ended Dec 2024 is 32.63% vs 93.33% in Dec 2023

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023

Compare Quarterly Results Of Fredun Pharma With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

101.84

2,396.57

-2,294.73

-95.75%

Other Operating Income

0.86

0.00

0.86

Total Operating income

102.70

2,396.57

-2,293.87

-95.71%

Raw Material Cost

73.18

179.72

-106.54

-59.28%

Purchase of Finished goods

0.00

445.60

-445.60

-100.00%

(Increase) / Decrease In Stocks

-0.26

34.08

-34.34

-100.76%

Employee Cost

5.85

521.79

-515.94

-98.88%

Power Cost

0.00

Manufacturing Expenses

4.73

0.00

4.73

Selling and Distribution Expenses

0.00

Other Expenses

5.97

474.45

-468.48

-98.74%

Total Expenditure (Excl Depreciation)

89.47

1,655.64

-1,566.17

-94.60%

Operating Profit (PBDIT) excl Other Income

13.23

740.93

-727.70

-98.21%

Other Income

0.00

69.82

-69.82

-100.00%

Operating Profit (PBDIT)

13.23

810.75

-797.52

-98.37%

Interest

5.00

199.47

-194.47

-97.49%

Exceptional Items

0.00

Gross Profit (PBDT)

8.23

611.28

-603.05

-98.65%

Depreciation

1.09

87.03

-85.94

-98.75%

Profit Before Tax

7.13

524.25

-517.12

-98.64%

Tax

1.80

107.87

-106.07

-98.33%

Provisions and contingencies

0.00

Profit After Tax

5.33

416.38

-411.05

-98.72%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

5.33

416.38

-411.05

-98.72%

Equity Capital

4.72

40.06

-35.34

-88.22%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

11.29

10.39

0.90

8.66%

Diluted Earnings per share

11.29

10.33

0.96

9.29%

Operating Profit Margin (Excl OI)

12.99%

30.92%

0.00

-17.93%

Gross Profit Margin

8.08%

25.51%

0.00

-17.43%

PAT Margin

5.23%

17.37%

0.00

-12.14%

Public Share Holdings (%)

51.07%

0.00%

51.07

51.07%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 101.84 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -4.72% vs 37.85% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 17.53% vs 11.59% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 5.33 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 24.82% vs 3.39% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 26.30% vs 21.97% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 13.23 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -5.09% vs 32.89% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 25.88% vs 43.58% in Dec 2023

Quarterly - Interest

Interest 5.00 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -5.84% vs 35.81% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 32.63% vs 93.33% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 12.99%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023